News

Under the new agreement, Fenwal will supply Cerus with finished disposable kits for the Intercept platelet and plasma systems through the end of 2013. Claes Glassell, president and

Mr Shanahan is the former president of Colgate-Palmolive Company and currently serves on the board of directors of Visa, Diageo and MSD Ignition, a privately held company. Mr

With the completion of this pivotal phase, Musculoskeletal Transplant Foundation (MTF) has successfully delivered to Orthofix a conclusive data package meeting the specifications provided by Orthofix under the

According to the company, the ViaDerm system provides a self-administered solution that enables the safe, reproducible and accurate delivery of a broad range of product candidates, including hydrophilic

Under the terms of the agreement, Teva will finance Jexys’s R&D program for the development of a high throughput drug discovery platform and in return will receive a

The products include Proteoderm’s special high end formulation and an over-the-counter formulation, currently under development. Proteoderm intends to sell to Sinoquest the pre-mixed material in bulk and a

Ortho-McNeil’s Phase I program will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of APD597 in single and multiple ascending dose studies in healthy volunteers. Ortho-McNeil’s planned clinical studies

The study is an open-label, dose-escalation trial expected to enroll up to 18 patients and to test three dose levels of FG-3019 administered via infusion every two weeks.

The Cross-Pilot is a laser support catheter for the 0.9 Turbo Elite laser ablation catheter. The Cross-Pilot was designed to provide additional support for reaching distal lesions. The